coagulation2-
-
Upload
ghada-khalifeh -
Category
Documents
-
view
216 -
download
0
Transcript of coagulation2-
-
8/7/2019 coagulation2-
1/7
PART IV Drugs used in disorders of coagulation
001. All of the following physiologic reactions are
involved in the control of bleeding EXCEPT:
a) Platelet adhesion reaction
b) Platelet release reaction
c) Activation of the antifibrinolytic system
d) Triggering of the coagulation process
002. Which of the following substances is
synthesized within vessel walls and inhibits
thrombogenesis ?
a) Thromboxane A2 (TXA2 )
b) Prostacyclin (PGI2 )
c) Prostaglandin ((PGE )
d) None of the above
003. All of the following groups of drugs are for
thrombosis treatment EXCEPT:
a) Anticoagulant drugs
b) Antifibrinolitic drugs
c) Fibrinolitic drugs
d) Antiplatelet drugs
Edited by Foxit ReaderCopyright(C) by Foxit Software Company,2005-2008For Evaluation Only.
c
b
b
-
8/7/2019 coagulation2-
2/7
004. Pick out the drug belonging to anticoagulants of
direct action :
a) Aspirin
b) Heparin
c) Dicumarol
d) Phenprocoumon
005.
Which of the following drugs has low-molecularweight ?
a) Dicumarol
b) Enoxaparin
c) Phenprocoumon
d) Heparin
006. Indicate the drug belonging to antagonists of
heparin :
a) Aspirin
b) Dicumarol
c) Dalteparin
d) Protamine sulfate
Edited by Foxit ReaderCopyright(C) by Foxit Software Company,2005-2008For Evaluation Only.
indirect action !!!
b
b
d
-
8/7/2019 coagulation2-
3/7
007. Tick the drug used as an oral anticoagulant :
a) Heparin
b) Daltreparin
c) Dicumarol
d) Enoxaparin
008. All of the following drugs are indirect acting
anticoagulants EXCEPT:
a) Dicumarol
b) Warfarin
c) Dalteparin
d) Phenindione
009. Which of the following drugs belongs to
coumarin derivatives?
a) Heparin
b) Enoxaparin
c) Dalteparin
d) Warfarin
Edited by Foxit ReaderCopyright(C) by Foxit Software Company,2005-2008For Evaluation Only.
NOT INcluded
c
c
d
-
8/7/2019 coagulation2-
4/7
010. Heparin is effective when administred orally.
This consideration is :
a) True
b) False
011. All of these drugs are antiplatelet agents
EXCEPT:
a) Aspirin
b) Urokinase
c) Ticlopidine
d) Clopidogrel
012. The use of heparin is recommended for
treatment of deep venous thrombosis. Thisstatement is :
a) True
b) False
Edited by Foxit ReaderCopyright(C) by Foxit Software Company,2005-2008For Evaluation Only.
b
b
a
-
8/7/2019 coagulation2-
5/7
013. Mechanism of aspirin action is :
a) Converts inactive plasminogen into active plasmin
b) Inhibits COX and thus thromboxane synthesis
c) Enhances the interaction between antitrombin III
and both thrombin and the factors involved in the
intrinsic clottingcascade
d) Inhibits the glycoprotein IIb/IIIa complex
014. Which doses of Aspirin may be more effective
in inhibiting Tromboxane A2 ?
a) Low
b) High
015. Which of the following drugs is an inhibitor ofplatelet glycoprotein IIb/IIIa receptors ?
a) Aspirin
b) Clopidogrel
c) Ticlopidine
d) Abciximab
016. Ticlopidine is an inhibitor of ADP-induced
platelet aggregation. Its :
a) True
b) False
Edited by Foxit ReaderCopyright(C) by Foxit Software Company,2005-2008For Evaluation Only.
b
a
d
a
-
8/7/2019 coagulation2-
6/7
017. Which of the following drugs is fiibrinolytic ?
a) Ticlopidine
b) Streptokinase
c) Aspirin
d) Warfarin
018. Mechanism of urokinase action is an inhibition
of Thromboxane A2. This statement is:
a) True
b) False
019. Fibrinolytic drugs are used for following
EXCEPT:
a) Central deep venous thrombosis
b) Multiple pulmonary emboli
c) Heart failure
d) Acute myocardial infarction
Edited by Foxit ReaderCopyright(C) by Foxit Software Company,2005-2008For Evaluation Only.
Not Included
b
b
c
-
8/7/2019 coagulation2-
7/7
020. Indicate the drug belonging to fibrinoliytic
inhibitors :
a) Aminocapronic acid
b) Ticlopidine
c) Streptokinase
d) Vitamin K
021.
Aminocapronic acid is a drug of choice fortreatment of :
a) Acute myocardial infarction
b) Bleeding from fibrinolytic therapy
c) Heart failure
d) Multiple pulmonary emboli
022. Tranexamic acid is an analog of aminocapronic
acid. Its :
a) True
b) False
Edited by Foxit ReaderCopyright(C) by Foxit Software Company,2005-2008For Evaluation Only.
a
b
a